Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
FY2024 Defense Appropriations Act
Fiscal 2024 Labor-HHS-Education Appropriations
P.L. 116-136, CARES Act
P.L. 113-5 Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
S. 1375 - HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 704 - REDI Act
S. 665, HR 4942 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
S. 1302 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
S. 1339 - Pharmacy Benefit Manager Reform Act
H.R. 2670 - National Defense Authorization Act
H.R. 2816 - Pharmacy Benefit Manager Sunshine and Accountability Act
H.R. 2679 - Pharmacy Benefits Manager Accountability Act
H.R. 2474 - The Strengthening Medicare for Patients and Providers Act
H.R.6371 - Provider Reimbursement Stability Act of 2023
S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act
Appropriation legislation related to Medicare Physician Payments cuts implemented in 2024
Appropriations legislation related to the Congressionally Directed Medical Research Program
Appropriations legislation related to the National Institutes of Health
S. 705 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 2761 - Specialty Physicians Advancing Rural Care (SPARC) Act
Duration: January 1, 2008
to
present
General Issues: Health Issues , Budget/Appropriations , Medicare/Medicaid , Immigration , Taxation/Internal Revenue Code , Medical/Disease Research/Clinical Labs
Spending: about $6,650,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), Veterans Affairs - Dept of (VA), Centers For Medicare and Medicaid Services (CMS), U.S. Senate,, Natl Institutes of Health (NIH)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 22.
Original Filing: 301575516.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
FY2024 Defense Appropriations Act
Fiscal 2024 Labor-HHS-Education Appropriations
P.L. 116-136, CARES Act
P.L. 113-5 Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
S. 1375 - HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 704 - REDI Act
S. 665, HR 4942 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
S. 1302 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
S. 1339 - Pharmacy Benefit Manager Reform Act
H.R. 2670 - National Defense Authorization Act
H.R. 2816 - Pharmacy Benefit Manager Sunshine and Accountability Act
H.R. 2679 - Pharmacy Benefits Manager Accountability Act
H.R. 2474 - The Strengthening Medicare for Patients and Providers Act
H.R.6371 - Provider Reimbursement Stability Act of 2023
S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act
Appropriation legislation related to Medicare Physician Payments cuts implemented in 2024
Appropriations legislation related to the Congressionally Directed Medical Research Program
Appropriations legislation related to the National Institutes of Health
S. 705 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 2761 - Specialty Physicians Advancing Rural Care (SPARC) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
4th Quarter, 2023
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 22.
Original Filing: 301540818.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
FY2024 Defense Appropriations Act
Fiscal 2024 Labor-HHS-Education Appropriations
P.L. 116-136, CARES Act
P.L. 113-5 Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
S. 1375 - HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 704 - REDI Act
S. 665 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
S. 1302 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
S. 1339 - Pharmacy Benefit Manager Reform Act
H.R. 2670 - National Defense Authorization Act
H.R. 2816 - Pharmacy Benefit Manager Sunshine and Accountability Act
H.R. 2679 - Pharmacy Benefits Manager Accountability Act
H.R. 2474 - The Strengthening Medicare for Patients and Providers Act
Draft H.R.___ - Provider Reimbursement Stability Act of 2023
S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act
Legislation related to Medicare Physician Payments cuts implemented in 2024
S. 705 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 2761 - Specialty Physicians Advancing Rural Care (SPARC) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2023
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301516370.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Draft Department of Defense FY2024 Appropriations Bill
Fiscal 2024 Labor-HHS-Education Appropriations
P.L. 116-136, CARES Act
P.L. 113-5 Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
S. 1375 - HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 704 - REDI Act
S. 665 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
S. 1302 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
S. 1339 - Pharmacy Benefit Manager Reform Act
H.R. 2670 - National Defense Authorization Act
H.R. 2816 - Pharmacy Benefit Manager Sunshine and Accountability Act
H.R. 2679 - Pharmacy Benefits Manager Accountability Act
H.R. 2474 - The Strengthening Medicare for Patients and Providers Act
Draft H.R.___ - Provider Reimbursement Stability Act of 2023
S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
2nd Quarter, 2023
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301491671.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Draft Department of Defense FY2024 Appropriations Bill
Fiscal 2024 Labor-HHS-Education Appropriations
P.L. 116-136, CARES Act
P.L. 113-5 Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
S. 1375 - HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 704 - REDI Act
S. 665 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
S. 1302 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
S. 1339 - Pharmacy Benefit Manager Reform Act
H.R. 2670 - National Defense Authorization Act
H.R. 2816 - Pharmacy Benefit Manager Sunshine and Accountability Act
H.R. 2679 - Pharmacy Benefits Manager Accountability Act
H.R. 2474 - The Strengthening Medicare for Patients and Providers Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
1st Quarter, 2023
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2023.
Original Filing: 301466839.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Draft Department of Defense FY2024 Appropriations Bill
P.L. 116-136, CARES Act
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 665 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
4th Quarter, 2022
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301443925.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Monitoring and outreach on legislative and administrative activity related to infrastructure.
Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution.
H.R. 4432 - Department of Defense Appropriations Act, FY2022.
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
H.R. 3684 - Infrastructure Investment and Jobs Act
S. 464 - Safe Step Act
H.R. 2163 - Safe Step Act
H.R. 1319 - American Rescue Plan Act of 2021
S. 834 - Resident Physician Shortage Reduction Act of 2021
H.R. 2256 - Resident Physician Shortage Reduction Act of 2021
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 - Medicare Sequester COVID Moratorium Act
S. 368 - Telehealth Modernization Act
H.R. 1332 - Telehealth Modernization Act
H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021
S. 1024 - Healthcare Workforce Resilience Act
H.R. 2255 - Healthcare Workforce Resilience Act
H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act
H.R. 3107 - The Improving Seniors Timely Access to Care Act
H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act
H.R. 315 - The Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
H.R. 5067 - Preserving Patient Access to Home Infusion Act
S. 2652 - Preserving Patient Access to Home Infusion Act
H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act
S. 1810 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 5376 - Build Back Better Act
S. 3314 - Supporting Medicare Providers Act
H.R. 6020 - Supporting Medicare Providers Act
H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act
S. 4408 Health and Location Data Protection Act of 2022
H.R. 4122 - Resident Education Deferred Interest Act or the REDI Act
S. 3658 - Resident Education Deferred Interest Act or the REDI Act
H.R.8800 - Supporting Medicare Providers Act of 2022
S.5194 - Protecting Medicare Patients and Physicians Act
H.R. 8800 - Protecting Medicare Patients and Physicians Act
H.R.9424 - Creating Access to Residency Education Act of 2022
FY2023 Labor Health and Human Services Appropriations content
Draft House, Department of Defense Appropriations Act, FY2023
Draft Senate, Department of Defense Appropriations Act, FY2023
Fiscal Year 2023 Omnibus
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2022
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301419468.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Monitoring and outreach on legislative and administrative activity related to infrastructure.
Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution.
H.R. 4432 - Department of Defense Appropriations Act, FY2022.
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
H.R. 3684 - Infrastructure Investment and Jobs Act
S. 464 - Safe Step Act
H.R. 2163 - Safe Step Act
H.R. 1319 - American Rescue Plan Act of 2021
S. 834 - Resident Physician Shortage Reduction Act of 2021
H.R. 2256 - Resident Physician Shortage Reduction Act of 2021
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 - Medicare Sequester COVID Moratorium Act
S. 368 - Telehealth Modernization Act
H.R. 1332 - Telehealth Modernization Act
H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021
S. 1024 - Healthcare Workforce Resilience Act
H.R. 2255 - Healthcare Workforce Resilience Act
H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act
H.R. 3107 - The Improving Seniors Timely Access to Care Act
H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act
H.R. 315 - The Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
H.R. 5067 - Preserving Patient Access to Home Infusion Act
S. 2652 - Preserving Patient Access to Home Infusion Act
H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act
S. 1810 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 5376 - Build Back Better Act
S. 3314 - Supporting Medicare Providers Act
H.R. 6020 - Supporting Medicare Providers Act
H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act
S. 4408 Health and Location Data Protection Act of 2022
H.R. 4122 - Resident Education Deferred Interest Act or the REDI Act
S. 3658 - Resident Education Deferred Interest Act or the REDI Act
H.R.8800 - Supporting Medicare Providers Act of 2022
FY2023 Labor Health and Human Services Appropriations content
Draft House, Department of Defense Appropriations Act, FY2023
Draft Senate, Department of Defense Appropriations Act, FY2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
2nd Quarter, 2022
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301394117.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Monitoring and outreach on legislative and administrative activity related to infrastructure.
Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution.
H.R. 4432 - Department of Defense Appropriations Act, FY2022.
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
H.R. 3684 - Infrastructure Investment and Jobs Act
S. 464 - Safe Step Act
H.R. 2163 - Safe Step Act
H.R. 1319 - American Rescue Plan Act of 2021
S. 834 - Resident Physician Shortage Reduction Act of 2021
H.R. 2256 - Resident Physician Shortage Reduction Act of 2021
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 - Medicare Sequester COVID Moratorium Act
S. 368 - Telehealth Modernization Act
H.R. 1332 - Telehealth Modernization Act
H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021
S. 1024 - Healthcare Workforce Resilience Act
H.R. 2255 - Healthcare Workforce Resilience Act
H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act
H.R. 3107 - The Improving Seniors Timely Access to Care Act
H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act
H.R. 315 - The Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
H.R. 5067 - Preserving Patient Access to Home Infusion Act
S. 2652 - Preserving Patient Access to Home Infusion Act
H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act
S. 1810 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 5376 - Build Back Better Act
S. 3314 - Supporting Medicare Providers Act
H.R. 6020 - Supporting Medicare Providers Act
H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act
S. 4408 Health and Location Data Protection Act of 2022
H.R. 4122 - Resident Education Deferred Interest Act or the REDI Act
S. 3658 - Resident Education Deferred Interest Act or the REDI Act
FY2023 Labor Health and Human Services Appropriations content
Draft House, Department of Defense Appropriations Act, FY2023
Draft Senate, Department of Defense Appropriations Act, FY2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
1st Quarter, 2022
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301371322.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Monitoring and outreach on legislative and administrative activity related to infrastructure.
Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution.
H.R. 4432 - Department of Defense Appropriations Act, FY2022.
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
H.R. 3684 - Infrastructure Investment and Jobs Act
S. 464 - Safe Step Act
H.R. 2163 - Safe Step Act
H.R. 1319 - American Rescue Plan Act of 2021
S. 834 - Resident Physician Shortage Reduction Act of 2021
H.R. 2256 - Resident Physician Shortage Reduction Act of 2021
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 - Medicare Sequester COVID Moratorium Act
S. 368 - Telehealth Modernization Act
H.R. 1332 - Telehealth Modernization Act
H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021
S. 1024 - Healthcare Workforce Resilience Act
H.R. 2255 - Healthcare Workforce Resilience Act
H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act
H.R. 3107 - The Improving Seniors Timely Access to Care Act
H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act
H.R. 315 - The Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
H.R. 5067 - Preserving Patient Access to Home Infusion Act
S. 2652 - Preserving Patient Access to Home Infusion Act
H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act
S. 1810 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 5376 - Build Back Better Act
S. 3314 - Supporting Medicare Providers Act
H.R. 6020 - Supporting Medicare Providers Act
H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act
FY2023 Labor Health and Human Services Appropriations content
FY2023 Department of Defense Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
4th Quarter, 2021
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301338474.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Monitoring and outreach on legislative and administrative activity related to infrastructure.
Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution.
H.R. 4432 - Department of Defense Appropriations Act, FY2022.
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
H.R. 3684 - Infrastructure Investment and Jobs Act
S. 464 - Safe Step Act
H.R. 2163 - Safe Step Act
H.R. 1319 - American Rescue Plan Act of 2021
S. 834 - Resident Physician Shortage Reduction Act of 2021
H.R. 2256 - Resident Physician Shortage Reduction Act of 2021
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 - Medicare Sequester COVID Moratorium Act
S. 368 - Telehealth Modernization Act
H.R. 1332 - Telehealth Modernization Act
H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021
S. 1024 - Healthcare Workforce Resilience Act
H.R. 2255 - Healthcare Workforce Resilience Act
H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act
H.R. 3107 - The Improving Seniors Timely Access to Care Act
H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act
H.R. 315 - The Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
H.R. 5067 - Preserving Patient Access to Home Infusion Act
S. 2652 - Preserving Patient Access to Home Infusion Act
H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act
S. 1810 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 5376 - Build Back Better Act
S. 3314 - Supporting Medicare Providers Act
H.R. 6020 - Supporting Medicare Providers Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2021
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2021.
Original Filing: 301313467.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
Monitoring and outreach on legislative and administrative activity related to infrastructure.
Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution.
H.R. 4432 - Department of Defense Appropriations Act, FY2022.
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
H.R. 3684 - Infrastructure Investment and Jobs Act
S. 464 - Safe Step Act
H.R. 2163 - Safe Step Act
H.R. 1319 - American Rescue Plan Act of 2021
S. 834 - Resident Physician Shortage Reduction Act of 2021
H.R. 2256 - Resident Physician Shortage Reduction Act of 2021
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 - Medicare Sequester COVID Moratorium Act
S. 368 - Telehealth Modernization Act
H.R. 1332 - Telehealth Modernization Act
H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021
S. 1024 - Healthcare Workforce Resilience Act
H.R. 2255 - Healthcare Workforce Resilience Act
H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act
H.R. 3107 - The Improving Seniors Timely Access to Care Act
H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act
H.R. 315 - The Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
H.R. 5067 - Preserving Patient Access to Home Infusion Act
S. 2652 - Preserving Patient Access to Home Infusion Act
H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act
S. 1810 - Conrad State 30 and Physician Access Reauthorization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
2nd Quarter, 2021
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2021.
Original Filing: 301290460.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak.
House Draft, Department of Defense Appropriations Act, FY2022
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
S. 464 Safe Step Act
H.R. 2163 Safe Step Act
H.R. 1319 American Rescue Plan Act of 2021
S. 834 Resident Physician Shortage Reduction Act of 2021
H.R. 2256 Resident Physician Shortage Reduction Act of 2021
H.R. 1868 To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 Medicare Sequester COVID Moratorium Act
S. 368 Telehealth Modernization Act
H.R. 1332 Telehealth Modernization Act
H.R. 366 Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 Pharmacy Benefit Manager Accountability Study Act of 2021
S. 1024 - Healthcare Workforce Resilience Act
H.R. 2255 - Healthcare Workforce Resilience Act
H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act
H.R. 3107 - The Improving Seniors Timely Access to Care Act
H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act
H.R. 315 - The Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak.
House Draft, Department of Defense Appropriations Act, FY2022
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
S. 464 Safe Step Act
H.R. 2163 Safe Step Act
H.R. 1319 American Rescue Plan Act of 2021
S. 834 Resident Physician Shortage Reduction Act of 2021
H.R. 2256 Resident Physician Shortage Reduction Act of 2021
Monitoring and outreach on legislative and administrative activity related to infrastructure.
H.R. 1868 To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 Medicare Sequester COVID Moratorium Act
S. 368 Telehealth Modernization Act
H.R. 1332 Telehealth Modernization Act
H.R. 366 Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 Pharmacy Benefit Manager Accountability Study Act of 2021
S. 1024 - Healthcare Workforce Resilience Act
H.R. 2255 - Healthcare Workforce Resilience Act
H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act
H.R. 3107 - The Improving Seniors Timely Access to Care Act
H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act
H.R. 315 - The Medicare Sequester COVID Moratorium Act
S. 748 - Medicare Sequester Relief Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2021
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301260925.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak.
House Draft, Department of Defense Appropriations Act, FY2022
Senate Draft, Department of Defense Appropriations Act, FY2022
P.L. 116-136, CARES Act
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act
P.L. 117-2, American Rescue Plan Act of 2021
S. 464 Safe Step Act
H.R. 2163 Safe Step Act
H.R. 1319 American Rescue Plan Act of 2021
S. 834 Resident Physician Shortage Reduction Act of 2021
H.R. 2256 Resident Physician Shortage Reduction Act of 2021
H.R. 1868 To prevent across-the-board direct spending cuts, and for other purposes
H.R. 315 Medicare Sequester COVID Moratorium Act
S. 368 Telehealth Modernization Act
H.R. 1332 Telehealth Modernization Act
H.R. 366 Protecting Access to Post-COVID-19 Telehealth Act of 2021
S. 298 Pharmacy Benefit Manager Accountability Study Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
4th Quarter, 2020
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 21, 2021.
Original Filing: 301245347.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak.
Monitoring and outreach on legislative activity related to the HEALS Act (S. 4317 - S. 4324).
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
House Draft, Department of Defense Appropriations Act, FY 2021.
Senate Draft, Department of Defense Appropriations Act, FY 2021.
H.R. 3, Lower Drug Costs Now Act of 2019.
H.R.748, CARES Act (P.L. 116-136) and other legislation related to the policies in reaction to the national health crisis.
H.R.7010, Paycheck Protection Program Flexibility Act of 2020 (P.L. 116-142).
H.R. 1158, FY2020 Consolidated Appropriations Act (Defense, CJS, FSGG, Homeland Security).
H.R. 1554, REDI Act.
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
H.R. 2279, Safe Step Act.
H.R. 2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
H.R. 2781, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness for Health Act of 2019.
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019.
H.R. 4378, FY2020 Continuing Appropriations Resolution (P.L. 116-59).
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
S. 1391, Fair Accountability and Innovative Research Drug Pricing Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019.
S. 2546, Safe Step Act.
H.R. 1763, Resident Physician Shortage Reduction Act.
S. 348, Resident Physician Shortage Reduction Act.
H.R. 6788, Workforce Resilience Act.
S. 3599, Workforce Resilience Act.
H.R. 5741, Strengthening Innovation in Medicare and Medicaid Act.
H.R. 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes
H.R. 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
H.R. 6644/S. 3741, Health Care at Home Act
H.R. 4932/S. 2741, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act
H.R. 266, Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139).
S. 4014, The Prioritized Paycheck Protection Program (P4) Act.
S. 4116, A bill to extend the authority for commitments for the paycheck protection program and separate amounts authorized for other loans under section 7(a) of the Small Business Act, and for other purposes (P.L. 116-147).
S.4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act.
H.R. 6800, The Heroes Act.
H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act (P.L. 116-159).
P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act.
H.R. 133: Consolidated Appropriations Act, 2021.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2020
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2020.
Original Filing: 301223240.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak.
CARES Act and other legislation related to the policies in reaction to the national health crisis. H.R. 7010, The Paycheck Protection Program Flexibility Act.
House Draft, Department of Defense Appropriations Act, FY 2021.
Senate Draft, Department of Defense Appropriations Act, FY 2021.
H.R. 3, Lower Drug Costs Now Act of 2019.
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 1158, FY2020 Consolidated Appropriations Act (Defense, CJS, FSGG, Homeland Security).
H.R. 1554, REDI Act.
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
H.R. 2279, Safe Step Act.
H.R. 2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
H.R. 2781, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness for Health Act of 2019.
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019.
H.R. 4378, FY2020 Continuing Appropriations Resolution (P.L. 116-59).
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
S. 1391, Fair Accountability and Innovative Research Drug Pricing Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019.
S. 2546, Safe Step Act.
H.R. 1763, Resident Physician Shortage Reduction Act.
S. 348, Resident Physician Shortage Reduction Act.
H.R. 6788, Workforce Resilience Act.
S. 3599, Workforce Resilience Act.
H.R. 5741, Strengthening Innovation in Medicare and Medicaid Act.
H.R.8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes
H.R. 6644/S. 3741, Health Care at Home Act
H.R. 4932/S. 2741, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
2nd Quarter, 2020
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2020.
Original Filing: 301201127.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak.
CARES Act and other legislation related to the policies in reaction to the national health crisis. H.R. 7010, The Paycheck Protection Program Flexibility Act.
House Draft, Department of Defense Appropriations Act, FY 2021.
Senate Draft, Department of Defense Appropriations Act, FY 2021.
H.R. 3, Lower Drug Costs Now Act of 2019.
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 1158, FY2020 Consolidated Appropriations Act (Defense, CJS, FSGG, Homeland Security).
H.R. 1554, REDI Act.
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
H.R. 2279, Safe Step Act.
H.R. 2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
H.R. 2781, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness for Health Act of 2019.
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019.
H.R. 4378, FY2020 Continuing Appropriations Resolution (P.L. 116-59).
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
S. 1391, Fair Accountability and Innovative Research Drug Pricing Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019.
S. 2546, Safe Step Act.
H.R. 1763, Resident Physician Shortage Reduction Act.
S. 348, Resident Physician Shortage Reduction Act.
H.R. 6788, Workforce Resilience Act.
S. 3599, Workforce Resilience Act.
H.R. 5741, Strengthening Innovation in Medicare and Medicaid Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
1st Quarter, 2020
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 21, 2020.
Original Filing: 301180316.xml
Lobbying Issues
Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response to the outbreak.
House Draft, Department of Defense Appropriations Act, FY 2021.
Senate Draft, Department of Defense Appropriations Act, FY 2021.
H.R. 3, Lower Drug Costs Now Act of 2019.
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 1158, FY2020 Consolidated Appropriations Act (Defense, CJS, FSGG, Homeland Security).
H.R. 1554, REDI Act.
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
H.R. 2279, Safe Step Act.
H.R. 2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
H.R. 2781, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness for Health Act of 2019.
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019.
H.R. 4378, FY2020 Continuing Appropriations Resolution (P.L. 116-59).
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
S. 1391, Fair Accountability and Innovative Research Drug Pricing Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019.
S. 2546 - Safe Step Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
4th Quarter, 2019
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 21, 2020.
Original Filing: 301127107.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 3, Lower Drug Costs Now Act of 2019.
H.R. 1158, FY2020 Consolidated Appropriations Act (Defense, CJS, FSGG, Homeland Security).
H.R. 1554, REDI Act.
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
H.R. 2279, Safe Step Act.
H.R. 2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
H.R. 2781, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness for Health Act of 2019.
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019.
H.R. 4378, FY2020 Continuing Appropriations Resolution (P.L. 116-59).
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
S. 1391, Fair Accountability and Innovative Research Drug Pricing Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019.
S. 2546 - Safe Step Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2019
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 21, 2019.
Original Filing: 301076995.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 3, Lower Drug Costs Now Act of 2019.
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
H.R. 2279, Safe Step Act.
H.R. 2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
H.R. 2740, FY2020 Consolidated Appropriations (Labor-HHS-ED, Defense, State-Foreign Operations, Energy and Water).
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019.
H.R. 4378, FY2020 Continuing Appropriations Resolution (P.L. 116-59).
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
S. 1391, Fair Accountability and Innovative Research Drug Pricing Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019.
S. 2546 - Safe Step Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
2nd Quarter, 2019
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 22, 2019.
Original Filing: 301058271.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
H.R. 2279, Safe Step Act.
H.R. 2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
H.R. 2740, FY2020 Consolidated Appropriations (Labor-HHS-ED, Defense, State-Foreign Operations, Energy and Water).
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019.
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
S. 1391, Fair Accountability and Innovative Research Drug Pricing Act of 2019.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD)
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
H.R. 2279, Safe Step Act.
H.R. 2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
H.R. 2740, FY2020 Consolidated Appropriations (Labor-HHS-ED, Defense, State-Foreign Operations, Energy and Water).
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019.
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
S. 1391, Fair Accountability and Innovative Research Drug Pricing Act of 2019.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Outreach and monitoring federal and legislative activity related to the Deferred Action
for Childhood Arrivals program.
Monitor implementation of revised Travel Ban Executive Order 13780 and related
actions.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD)
1st Quarter, 2019
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 22, 2019.
Original Filing: 301036542.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
House Draft, Department of Defense Appropriations Act, FY 2020.
Senate Draft, Department of Defense Appropriations Act, FY 2020.
House Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2020.
Senate Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2020.
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD)
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
House Draft, Department of Defense Appropriations Act, FY 2020.
Senate Draft, Department of Defense Appropriations Act, FY 2020.
House Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2020.
Senate Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2020.
H.R. 2087, To amend title XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program, and for other purposes.
S. 64, Preserve Access to Affordable Generics and Biosimilars Act.
S. 283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Outreach and monitoring federal and legislative activity related to the Deferred Action
for Childhood Arrivals program.
Monitor implementation of revised Travel Ban Executive Order 13780 and related
actions.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD)
4th Quarter, 2018
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 22, 2019.
Original Filing: 301016904.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.J. Res. 143, Continuing appropriations for fiscal year 2019. (P.L. 115-298)
H.R. 6, SUPPORT for Patients and Communities Act. (P.L. 115-271)
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1898, To improve access to, and utilization of, bone mass measurement benefits.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2141, Conrad State 30 and Physician Access Reauthorization Act.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3767, Ensuring Children's Access to Specialty Care Act of 2017.
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018.
H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018.
H.R.6157, Defense and Labor, Health and Human Services Consolidated Appropriations Act, 2019. (P.L. 115-245)
H.R. 6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 898, Conrad State 30 and Physician Access Reauthorization Act.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 2553, Know the Lowest Price Act of 2018 (P.L. 115-262).
S. 2554, Patient Right to Know Drug Prices Act (P.L. 115-263).
S. 2908, To provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
S. 3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 3159, Department of Defense Appropriations Act, 2019.
S. 3160, To improve access to, and utilization of, bone mass measurement benefits.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD)
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 6, SUPPORT for Patients and Communities Act.
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1898, To improve access to, and utilization of, bone mass measurement benefits.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2141, Conrad State 30 and Physician Access Reauthorization Act.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3767, Ensuring Children's Access to Specialty Care Act of 2017.
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018.
H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018.
H.R.6157, Defense and Labor, Health and Human Services Consolidated Appropriations Act, 2019.
H.R. 6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 898, Conrad State 30 and Physician Access Reauthorization Act.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 2553, Know the Lowest Price Act of 2018 (P.L. 115-262).
S. 2554, Patient Right to Know Drug Prices Act (P.L. 115-263).
S. 2908, To provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
S. 3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 3160, To improve access to, and utilization of, bone mass measurement benefits.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Outreach and monitoring federal and legislative activity related to the Deferred Action
for Childhood Arrivals program.
Monitor implementation of revised Travel Ban Executive Order 13780 and related
actions.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD)
3rd Quarter, 2018
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 22, 2018.
Original Filing: 300998282.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 6, SUPPORT for Patients and Communities Act.
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1898, To improve access to, and utilization of, bone mass measurement benefits.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2141, Conrad State 30 and Physician Access Reauthorization Act.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3767, Ensuring Children's Access to Specialty Care Act of 2017.
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018.
H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018.
H.R.6157, Defense and Labor, Health and Human Services Consolidated Appropriations Act, 2019.
H.R. 6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 898, Conrad State 30 and Physician Access Reauthorization Act.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 2553, Know the Lowest Price Act of 2018 (P.L. 115-262).
S. 2554, Patient Right to Know Drug Prices Act (P.L. 115-263).
S. 2908, To provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
S. 3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 3159, Department of Defense Appropriations Act, 2019.
S. 3160, To improve access to, and utilization of, bone mass measurement benefits.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD) Veterans Affairs - Dept of (VA)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
Lobbying Issues
Outreach and monitoring federal and legislative activity related to the Deferred Action
for Childhood Arrivals program.
Monitor implementation of revised Travel Ban Executive Order 13780 and related
actions.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Veterans Affairs - Dept of (VA) Defense - Dept of (DOD)
2nd Quarter, 2018
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2018.
Original Filing: 300974622.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
House Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
H.R. 6, SUPPORT for Patients and Communities Act.
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1898, To improve access to, and utilization of, bone mass measurement benefits.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2141, Conrad State 30 and Physician Access Reauthorization Act.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3767, Ensuring Children's Access to Specialty Care Act of 2017.
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018.
H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018.
H.R. 6157, Department of Defense Appropriations Act, 2019.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 898, Conrad State 30 and Physician Access Reauthorization Act.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 2553, Know the Lowest Price Act of 2018.
S. 2554, Patient Right to Know Drug Prices Act.
S. 2908, To provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
S. 3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 3159, Department of Defense Appropriations Act, 2019.
S. 3160, To improve access to, and utilization of, bone mass measurement benefits.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
Lobbying Issues
Monitor federal and legislative activity related to the Deferred Action
for Childhood Arrivals program.
Monitor implementation of revised Travel Ban Executive Order 13780 and related
actions.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2018
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2018.
Original Filing: 300958371.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor the implementation of the Consolidated Appropriations Act 2017, P.L. 115-31.
Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
Draft, Department of Defense Appropriations Act, 2019
Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
H. J. Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (P.L. 115-90).
H.R. 195, Extension of Continuing Appropriations Act, 2018 (P.L. 115-120).
H.R. 601, Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (P.L. 115-56).
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96).
H.R. 1625, Consolidated Omnibus Appropriations 2018 (P.L. 115-124).
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123).
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S.2553, Know the Lowest Price Act of 2018.
S.2554, Patient Right to Know Drug Prices Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor the implementation of the Consolidated Appropriations Act 2017, P.L. 115-31.
Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
Draft, Department of Defense Appropriations Act, 2019
Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
H. J. Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (P.L. 115-90).
H.R. 195, Extension of Continuing Appropriations Act, 2018 (P.L. 115-120).
H.R. 601, Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (P.L. 115-56).
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96).
H.R. 1625, Consolidated Omnibus Appropriations 2018 (P.L. 115-124).
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123).
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S.2553, Know the Lowest Price Act of 2018.
S.2554, Patient Right to Know Drug Prices Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2017
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 22, 2018.
Original Filing: 300937619.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor implementation of revised Travel Ban Executive Order 13780 and related actions.
Monitor the implementation of the Consolidated Appropriations Act 2017, P.L. 115-31.
Draft, Graham-Cassidy healthcare legislation.
H. J. Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (P.L. 115-90).
H.Res. 506, "Rheumatic Disease Awareness Month".
H.R. 1, Tax Cuts and Jobs Act (P.L. 115-97).
H.R. 601, Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (P.L. 115-56).
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96).
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3358, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3921, HEALTHY KIDS Act.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.
S. 1827, KIDS Act of 2017.
P.L. 115-52, FDA Reauthorization Act of 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor implementation of revised Travel Ban Executive Order 13780 and related actions.
Monitor the implementation of the Consolidated Appropriations Act 2017, P.L. 115-31.
Draft, Graham-Cassidy healthcare legislation.
H. J. Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (P.L. 115-90).
H.Res. 506, "Rheumatic Disease Awareness Month".
H.R. 1, Tax Cuts and Jobs Act (P.L. 115-97).
H.R. 601, Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (P.L. 115-56).
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96).
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3358, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3921, HEALTHY KIDS Act.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.
S. 1827, KIDS Act of 2017.
P.L. 115-52, FDA Reauthorization Act of 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2017
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 23, 2017.
Original Filing: 300917267.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor implementation of revised Travel Ban Executive Order 13780 and related actions.
Monitor the implementation of the Consolidated Appropriations Act 2017, P.L. 115-31.
Draft, Graham-Cassidy healthcare legislation.
H.Res. 506, "Rheumatic Disease Awareness Month".
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1301, Department of Defense Appropriations, FY 2017.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3219, Make America Secure Appropriations Act, 2018.
H.R. 3358, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3921, HEALTHY KIDS Act.
S. 222, Obamacare Replacement Act.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.
S. 1827, KIDS Act of 2017.
P.L. 115-52, FDA Reauthorization Act of 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor implementation of revised Travel Ban Executive Order 13780 and related actions.
Monitor the implementation of the Consolidated Appropriations Act 2017, P.L. 115-31.
Draft, Graham-Cassidy healthcare legislation.
H.Res. 506, "Rheumatic Disease Awareness Month".
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1301, Department of Defense Appropriations, FY 2017.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3219, Make America Secure Appropriations Act, 2018.
H.R. 3358, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3921, HEALTHY KIDS Act.
S. 222, Obamacare Replacement Act.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018.
S. 1827, KIDS Act of 2017.
P.L. 115-52, FDA Reauthorization Act of 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2017
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2017.
Original Filing: 300897547.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor implementation of Revised Travel Ban Executive Order.
Monitor the implementation of the Consolidated Appropriations Act 2017, P.L. 115-31.
Senate Draft, Department of Defense Appropriations, FY 2017.
Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1301, Department of Defense Appropriations, FY 2017.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2430, FDA Reauthorization Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 934, FDA Reauthorization Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor implementation of Revised Travel Ban Executive Order.
Draft, Department of Defense Appropriations, FY 2017.
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1301, Department of Defense Appropriations, FY 2017.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2430, FDA Reauthorization Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 934, FDA Reauthorization Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2017
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2017.
Original Filing: 300878133.xml
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor implementation of Revised Travel Ban Executive Order.
Draft, Department of Defense Appropriations, FY 2017.
Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Draft, Department of Defense Appropriations, FY 2017.
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 884, A bill to amend the Omnibus Budget Reconciliation Act of 1993 to require the Bureau of Land Management to provide a claimant of a small miner waiver from claim maintenance fees with a period of 60 days after written receipt of 1 or more defects is provided to the claimant by registered mail to cure the 1 or more defects or pay the claim maintenance fee, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
Monitor implementation of Revised Travel Ban Executive Order.
Draft, Department of Defense Appropriations, FY 2017.
Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Draft, Department of Defense Appropriations, FY 2017.
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 884, A bill to amend the Omnibus Budget Reconciliation Act of 1993 to require the Bureau of Land Management to provide a claimant of a small miner waiver from claim maintenance fees with a period of 60 days after written receipt of 1 or more defects is provided to the claimant by registered mail to cure the 1 or more defects or pay the claim maintenance fee, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2016
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 23, 2017.
Original Filing: 300857601.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy.
Monitor federal issues and legislation related to Medicare reimbursement.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Extend Section 3111, P.L. 111-148.
Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R.775, Medicare Access to Rehabilitation Services Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 3309, Flex-IT 2 Act
H.R. 4227, Medicare Advantage Bill of Rights.
H.R. 4848, HIP Act
H.R. 4909, National Defense Authorization Act for Fiscal Year 2017
H.R. 5001, Flexibility in Electronic Health Record Reporting Act.
H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
H.R. 5293, Department of Defense Appropriations, FY 2017.
H.R.5721, Local Coverage Determination Clarification Act
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
S.539, Medicare Access to Rehabilitation Services Act of 2015.
S. 2392, Medicare Advantage Bill of Rights.
S. 2511, Improving Health Information Technology Act.
S. 2822, Flexibility in Electronic Health Record Reporting Act
S. 2943, National Defense Authorization Act for Fiscal Year 2017
S. 2978, The Protect Continuing Physician Education and Patient Care Act.
S. 3000, Department of Defense Appropriations, FY 2017.
S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
S.3173, EHR Regulatory Relief Act.
Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511.
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education.
Funding for Pediatric Subspecialty Loan Repayment Program.
Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy.
Monitor federal issues and legislation related to Medicare reimbursement.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Extend Section 3111, P.L. 111-148.
Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R.775, Medicare Access to Rehabilitation Services Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 3309, Flex-IT 2 Act
H.R. 4227, Medicare Advantage Bill of Rights.
H.R. 4848, HIP Act
H.R. 4909, National Defense Authorization Act for Fiscal Year 2017
H.R. 5001, Flexibility in Electronic Health Record Reporting Act.
H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
H.R. 5293, Department of Defense Appropriations, FY 2017.
H.R.5721, Local Coverage Determination Clarification Act
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
S.539, Medicare Access to Rehabilitation Services Act of 2015.
S. 2392, Medicare Advantage Bill of Rights.
S. 2511, Improving Health Information Technology Act.
S. 2822, Flexibility in Electronic Health Record Reporting Act
S. 2943, National Defense Authorization Act for Fiscal Year 2017
S. 2978, The Protect Continuing Physician Education and Patient Care Act.
S. 3000, Department of Defense Appropriations, FY 2017.
S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
S.3173, EHR Regulatory Relief Act.
Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511.
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education.
Funding for Pediatric Subspecialty Loan Repayment Program.
Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2016
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2016.
Original Filing: 300839849.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy.
Monitor federal issues and legislation related to Medicare reimbursement.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Extend Section 3111, P.L. 111-148.
Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R.775, Medicare Access to Rehabilitation Services Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 3309, Flex-IT 2 Act
H.R. 4227, Medicare Advantage Bill of Rights.
H.R. 4848, HIP Act
H.R. 4909, National Defense Authorization Act for Fiscal Year 2017
H.R. 5001, Flexibility in Electronic Health Record Reporting Act.
H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
H.R. 5293, Department of Defense Appropriations, FY 2017.
H.R.5721, Local Coverage Determination Clarification Act
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
S.539, Medicare Access to Rehabilitation Services Act of 2015.
S. 2392, Medicare Advantage Bill of Rights.
S. 2511, Improving Health Information Technology Act.
S. 2822, Flexibility in Electronic Health Record Reporting Act
S. 2943, National Defense Authorization Act for Fiscal Year 2017
S. 2978, The Protect Continuing Physician Education and Patient Care Act.
S. 3000, Department of Defense Appropriations, FY 2017.
S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
S.3173, EHR Regulatory Relief Act.
Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511.
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education.
Funding for Pediatric Subspecialty Loan Repayment Program.
Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy.
Monitor federal issues and legislation related to Medicare reimbursement.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Extend Section 3111, P.L. 111-148.
Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R.775, Medicare Access to Rehabilitation Services Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 3309, Flex-IT 2 Act
H.R. 4227, Medicare Advantage Bill of Rights.
H.R. 4848, HIP Act
H.R. 4909, National Defense Authorization Act for Fiscal Year 2017
H.R. 5001, Flexibility in Electronic Health Record Reporting Act.
H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
H.R. 5293, Department of Defense Appropriations, FY 2017.
H.R.5721, Local Coverage Determination Clarification Act
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
S.539, Medicare Access to Rehabilitation Services Act of 2015.
S. 2392, Medicare Advantage Bill of Rights.
S. 2511, Improving Health Information Technology Act.
S. 2822, Flexibility in Electronic Health Record Reporting Act
S. 2943, National Defense Authorization Act for Fiscal Year 2017
S. 2978, The Protect Continuing Physician Education and Patient Care Act.
S. 3000, Department of Defense Appropriations, FY 2017.
S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
S.3173, EHR Regulatory Relief Act.
Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511.
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education.
Funding for Pediatric Subspecialty Loan Repayment Program.
Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2016
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2016.
Original Filing: 300821876.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy.
Monitor federal issues and legislation related to Medicare reimbursement.
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Extend Section 3111, P.L. 111-148.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Monitor the implementation of Consolidated Appropriations Act, 2016 (P.L. 114-113).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R.775, Medicare Access to Rehabilitation Services Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 3309, Flex-IT 2 Act
H.R. 4227, Medicare Advantage Bill of Rights.
H.R. 4848, HIP Act
H.R. 4909, National Defense Authorization Act for Fiscal Year 2017
H.R. 5001, Flexibility in Electronic Health Record Reporting Act
H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
H.R. 5293, Department of Defense Appropriations, FY 2017.
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
S.539, Medicare Access to Rehabilitation Services Act of 2015.
S. 1695, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
S. 2392, Medicare Advantage Bill of Rights.
S. 2511, Improving Health Information Technology Act.
S. 2822, Flexibility in Electronic Health Record Reporting Act
S. 2943, National Defense Authorization Act for Fiscal Year 2017
S. 3000, Department of Defense Appropriations, FY 2017.
S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511.
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education.
Funding for Pediatric Subspecialty Loan Repayment Program.
Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Budget/Appropriations
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy.
Monitor federal issues and legislation related to Medicare reimbursement.
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Extend Section 3111, P.L. 111-148.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Monitor the implementation of Consolidated Appropriations Act, 2016 (P.L. 114-113).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R.775, Medicare Access to Rehabilitation Services Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 3309, Flex-IT 2 Act
H.R. 4227, Medicare Advantage Bill of Rights.
H.R. 4848, HIP Act
H.R. 4909, National Defense Authorization Act for Fiscal Year 2017
H.R. 5001, Flexibility in Electronic Health Record Reporting Act
H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
H.R. 5293, Department of Defense Appropriations, FY 2017.
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
S.539, Medicare Access to Rehabilitation Services Act of 2015.
S. 1695, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
S. 2392, Medicare Advantage Bill of Rights.
S. 2511, Improving Health Information Technology Act.
S. 2822, Flexibility in Electronic Health Record Reporting Act
S. 2943, National Defense Authorization Act for Fiscal Year 2017
S. 3000, Department of Defense Appropriations, FY 2017.
S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511.
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education.
Funding for Pediatric Subspecialty Loan Repayment Program.
Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2016
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2016.
Original Filing: 300803481.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy.
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor the implementation of Consolidated Appropriations Act, 2016 (P.L. 114-113).
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
S. 1695, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 4227, Medicare Advantage Bill of Rights.
S. 2392, Medicare Advantage Bill of Rights.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education.
Funding for Pediatric Subspecialty Loan Repayment Program.
Defense Authorization Act for Fiscal Year 2016.
Monitor federal issues and legislation related to healthcare policy.
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor the implementation of Consolidated Appropriations Act, 2016 (P.L. 114-113).
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
S. 1695, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 4227, Medicare Advantage Bill of Rights.
S. 2392, Medicare Advantage Bill of Rights.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy.
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor the implementation of Consolidated Appropriations Act, 2016 (P.L. 114-113).
Extend Section 3111, P.L. 111-148.
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
H.R. 6, House 21st Century Cures Act.
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015.
H.R. 1416, Cancer Patient Protection Act of 2015.
H.R. 1600, Patients' Access to Treatments Act of 2015.
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015.
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015.
H.R. 2256, Veterans Information Modernization Act.
H.R. 2464, Demanding Accountability for Veterans Act of 2015.
H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
S. 1695, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
H.R. 4227, Medicare Advantage Bill of Rights.
S. 2392, Medicare Advantage Bill of Rights.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2015
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 20, 2016.
Original Filing: 300784256.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10); Monitor implementation, P.L. 111-148; Monitor activity related to reauthorization of National All Schedules Prescription Electronic Reporting Act (P.L. 109-60). H.R. 1600, Patients' Access to Treatments Act of 2015; Extension, Section 3111, P.L. 111-148; H.R. 6, House 21st Century Cures Act; H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes; H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015; H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015; H.R. 3309, Flex-IT 2 Act; H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015;
S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015; H.R. 2256, Veterans Information Modernization Act; H.R. 2464, Demanding Accountability for Veterans Act of 2015.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10); Monitor implementation, P.L. 114-10; Monitor implementation of the Patient Protection and Affordable Care Act, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 1416, Cancer Patient Protection Act of 2015; H.R. 775 / S. 539, Medicare Access to Rehabilitation Services Act of 2015; H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015; H.R. 3261 / S. 1884 Medicare Prescription Drug Savings and Choice Act of 2015; H.R. 4227 / S. 2392, Medicare Advantage Bill of Rights.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education; Funding for Pediatric Subspecialty Loan Repayment Program; H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S. 1695, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S.1376, S.289 - American Cures Act; Defense Authorization Act for Fiscal Year 2016; Monitor the implementation of Consolidated Appropriations Act, 2016 (P.L. 114-113)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2015.
Original Filing: 300765352.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; Monitor implementation, P.L. 111-148; H.R. 2126, Cutting Costly Codes Act of 2015; H.R. 2247, ICD-TEN Act; H.R. 1600, Patients' Access to Treatments Act of 2015; Extension, Section 3111, P.L. 111-148; H.R. 6, House 21st Century Cures Act; H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes; H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015; H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015; H.R. 3309, Flex-IT 2 Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10); Monitor implementation, P.L. 114-10; Monitor implementation, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 1416, Cancer Patient Protection Act of 2015; H.R. 775 / S. 539, Medicare Access to Rehabilitation Services Act of 2015; H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015; H.R. 3261 / S. 1884 Medicare Prescription Drug Savings and Choice Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education; Funding for Pediatric Subspecialty Loan Repayment Program; H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S. 1695, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S.1376, S.289 - American Cures Act; Defense Authorization Act for Fiscal Year 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2015.
Original Filing: 300746606.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; Monitor implementation, P.L. 111-148; H.R. 2126, Cutting Costly Codes Act of 2015; H.R. 2247, ICD-TEN Act; H.R. 1600, Patients' Access to Treatments Act of 2015; Extension, Section 3111, P.L. 111-148; H.R. 6, House 21st Century Cures Act; H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes; H.R. 1859, Ensuring Children's Access to Specialty Care Act of 2015; H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10); Monitor implementation, P.L. 114-10; Monitor implementation, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 1416, Cancer Patient Protection Act of 2015; H.R. 775 / S. 539, Medicare Access to Rehabilitation Services Act of 2015; H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, DOD, related to arthritis and rheumatic disease research and education; Funding for Pediatric Subspecialty Loan Repayment Program; H.R. 3020, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S. 1695, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S.1376, S.289 - American Cures Act; Defense Authorization Act for Fiscal Year 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2015.
Original Filing: 300727893.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; Monitor implementation, P.L. 111-148; H.R. 1600, Patients' Access to Treatments Act of 2015; Extension, Section 3111, P.L. 111-148; Draft, House 21st Century Cures Act; H.R.293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes; H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Repeal Medicare Sustainable Growth Rate formula; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Monitor implementation, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 1416, Cancer Patient Protection Act of 2015; H.R. 775 / S. 539, Medicare Access to Rehabilitation Services Act of 2015; H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research and education; Funding for Pediatric Subspecialty Loan Repayment Program; Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S.289 - American Cures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2014
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 20, 2015.
Original Filing: 300708237.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; Monitor implementation, P.L. 111-148; H.R. 460, Patients Access to Treatment Act of 2013; Extension, Section 3111, P.L. 111-148; H.R. 1701 / S. 972, Cutting Costly Codes Act; H.R. 1429 Scleroderma Research and Awareness Act; H.R. 2663 / S. 1422, To Amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings; H.R. 1827, Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013; H.R. 4282, Creating Access to Residency Education Act of 2014; H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under EHR incentive payment programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Repeal Medicare Sustainable Growth Rate formula; Monitor implementation, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act; H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013; S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013; H.R. 4302, Protecting Access to Medicare Act; H.R. 1416, Cancer Patient Protection Act; H.R. 2305 / S. 1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act; H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under EHR incentive payment programs; H.R. 800, To exclude prompt pay discounts from ASP formula
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research and education; Funding for Pediatric Subspecialty Loan Repayment Program; Monitor passage and implementation of Consolidated and Further Continuing Appropriations Act, 2015 (P.L. 113-235); S. 2115, American Cures Act; H.R. 4384, America HEALS Act; S. 2658, Accelerating Biomedical Research Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2014
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300689225.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; Monitor implementation, P.L. 111-148; H.R. 460, Patients Access to Treatment Act of 2013; Extension, Section 3111, P.L. 111-148; H.R. 1701 / S. 972, Cutting Costly Codes Act; H.R. 1429 Scleroderma Research and Awareness Act; H.R. 2663 / S. 1422, To Amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings; H.R. 1827, Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013; H.R.4282, Creating Access to Residency Education Act of 2014; H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under EHR incentive payment programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Repeal Sustainable Growth Rate formula; Monitor implementation, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 4015 / S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act; S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013; H.R. 1416, Cancer Patient Protection Act; H.R. 2305 / S. 1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act; H.R. 2810, Medicare Patient Access and Quality Improvement Act; H.R. 4302, Protecting Access to Medicare Act; H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under EHR incentive payment programs; H.R. 800, To exclude prompt pay discounts from ASP formula
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research and education; Funding for Pediatric Subspecialty Loan Repayment Program; Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S. 2115, American Cures Act; H.R. 4384, America HEALS Act; S. 2658, Accelerating Biomedical Research Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 21, 2014.
Original Filing: 300669553.xml
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research; Funding for Pediatric Subspecialty Loan Repayment Program; Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; S. 2115, American Cures Act; H.R. 4384, America HEALS Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; Monitor implementation, P.L. 111-148; H.R. 460, Patients Access to Treatment Act of 2013; Extension, Section 3111, P.L. 111-148; H.R. 1701 / S. 972, Cutting Costly Codes Act; H.R. 1429 Scleroderma Research and Awareness Act; H.R. 2663 / S. 1422 To Amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings; H.R. 1827, Pediatric Subspecialty and Mental Health Workforce Reauthorization Act of 2013; H.R.4282, Creating Access to Residency Education Act of 2014
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Repeal Sustainable Growth Rate formula; Monitor implementation, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 4015 / S. 2000 SGR Repeal and Medicare Provider Payment Modernization Act; S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013; H.R. 1416 Cancer Patient Protection Act; H.R. 2305 / S. 1123 Preventing and Reducing Improper Medicare and Medicaid Expenditures Act; H.R. 2810 Medicare Patient Access and Quality Improvement Act; H.R. 4302 Protecting Access to Medicare Act; H.R. 800 Exclude prompt pay discounts from ASP formula
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2014
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 22, 2014.
Original Filing: 300649617.xml
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research; Monitor passage of FY 2014 omnibus appropriations bill (P.L. 113-76); Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; Monitor implementation, P.L. 111-148; Extension, Section 3111, P.L. 111-148; H.R. 460, Patients' Access to Treatments Act; H.R. 1701 / S. 972, Cutting Costly Codes Act; H.R. 1429 Scleroderma Research and Awareness Act; H.R. 2663 / S. 1422 To Amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Repeal Sustainable Growth Rate formula; Monitor implementation, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 4015 / S. 2000 SGR Repeal and Medicare Provider Payment Modernization Act; H.R. 1416 Cancer Patient Protection Act; H.R. 2305 / S. 1123 Preventing and Reducing Improper Medicare and Medicaid Expenditures Act; H.R. 2810 Medicare Patient Access and Quality Improvement Act; H.R. 4302 Protecting Access to Medicare Act; H.R. 800 Exclude prompt pay discounts from ASP formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2013
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 21, 2014.
Original Filing: 300626937.xml
Lobbying Issues
Monitor federal issues and legislation related to healthcare policy; Monitor implementation, P.L. 111-148; Extension, Section 3111, P.L. 111-148; H.R. 460, Patients' Access to Treatments Act; H.R. 1416, Cancer Patient Protection Act; H.R. 1701 / S. 972, Cutting Costly Codes Act; H.R. 2663 / S. 1422, To Amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings; S. 1872, Amend title XVIII of the Social Security Act to reform the sustainable growth rate; H.R. 800, Prompt pay discounts
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research; Monitor passage of Continuing Appropriations Act, 2014 (P.L. 113-46); Monitor passage of the Bipartisan Budget Act of 2013 (P.L. 113-67); Draft, FY 2014 omnibus appropriations bill; Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013; S. 1284, Departments of Labor, Health and Human Serivices, and Education, and Related Agencies Appropriations Act, 2014
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2013
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 21, 2013.
Original Filing: 300607633.xml
Lobbying Issues
H.R. 2810 Medicare Patient Access and Quality Improvement Act; Draft, Senate bill to reform sustainable growth rate and Medicare physician payment formu; Monitor implementation, P.L. 111-148; Extension, Section 3111, P.L. 111-148; H.R. 1416 Cancer Patient Protection Act; H.R. 351 / S. 351 Protecting Access to Medicare Act; H.R. 800 Exclude prompt pay discounts; H.R. 1310 / S. 236 Medicare Patient Empowerment Act; H.R. 2305 / S. 1123 Preventing and Reducing Improper Medicare Expenditures Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research; Issues related to sequestration and the NIH, CDC, and FDA; Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; S. 1284 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.J. Res. 59, Continuing Appropriations Resolution
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 460 Patients' Access to Treatments Act; H.R. 1701 / S. 972 Cutting Costly Codes Act; H.R. 2663 / S. 1422 bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings; H.R. 1201 Training Tomorrow's Doctors Today Act; H.R. 487 Primary Care Workforce Access Improvement Act; H.R. 1429 Scleroderma Research and Awareness Act; H.R. 1285 / S. 621 hydrocodone a schedule II drug; H.R. 1331 Electronic Health Records Improvement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2013
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 22, 2013.
Original Filing: 300586509.xml
Lobbying Issues
Drafts, House and Senate bills to reform sustainable growth rate and Medicare physican payment; H.R. 1416 Cancer Patient Protection Act; Monitor implementation, P.L. 111-148 and extend Section 3111; H.R. 351 / S. 351 Protecting Access to Medicare Act; H.R. 1310 / S. 236 Medicare Patient Empowerment Act; H.R. 1102 / S. 117 Medicare Prescription Drug Price Negotiation Act; H.R. 2305 / S. 1123 Preventing, Reducing Improper Medicare Expenditures Act; H.R. 800 Exclude prompt pay discounts from ASP
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research; Monitor Implementation of American Taxpayer Relief Act of 2012, P.L. 112-240; Issues related to sequestration and the NIH, CDC, and FDA; Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013; S. 1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 460 Patients' Access to Treatments Act; H.R. 1701 / S. 972 Cutting Costly Codes Act; Monitor implementation of P.L. 111-148; H.R. 487 Primary Care Workforce Access Improvement Act; H.R. 1180 / S. 577 Resident Physician Shortage Reduction Act; H.R. 1429, Scleroderma Research and Awareness Act; H.R. 1201 Training Tomorrow's Doctors Today Act; H.R. 1285 / S. 621 Amend Controlled Substances Act, hydrocodone a schedule II drug; H.R. 1331 Electronic Health Records Improvement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2013
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 22, 2013.
Original Filing: 300564667.xml
Lobbying Issues
Repeal Sustainable Growth Rate formula; Monitor implementation, P.L. 111-148; Extend Section 3111, P.L. 111-148; H.R. 351 / S. 351 Protecting Seniors' Access to Medicare Act; H.R. 574 Medicare Physician Payment Innovation Act; H.R. 1310 / S. 236 Medicare Patient Empowerment Act; H.R. 1102 / S. 117 Medicare Prescription Drug Price Negotiation Act; H.R. 1416 To terminate application of sequestration to payment for certain physician-administered drugs; H.R. 800 Exclude prompt pay discounts from ASP
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research; Monitor Implementation of American Taxpayer Relief Act of 2012, P.L. 112-240; Issues related to sequestration and the National Institutes of Health, Centers for Disease Control, and Food and Drug Administration; H.R. 1301 Inspiring Scientific Research and Innovation Supplemental Appropriations Act; H.R. 729 Medical Research Protection Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 460 Patients' Access to Treatments Act; H.R. 487 Primary Care Workforce Access Improvement Act; H.R. 1180 / S. 577 Resident Physician Shortage Reduction Act; H.R. 1201 Training Tomorrow's Doctors Today Act; H.R. 1285 / S. 621 To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; H.R. 1309 Health Information Technology Reform Act; H.R. 1331 Electronic Health Records Improvement Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2012
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 22, 2013.
Original Filing: 300542865.xml
Lobbying Issues
Repeal Sustainable Growth Rate formula; Monitor implementation of P.L. 111-148; Extension of Section 3111, P.L. 111-148; H.R. 5707 Medicare Physician Payment Innovation Act; H.R. 2020 / S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; H.R. 1700 / S. 1042 Medicare Patient Empowerment Act; H.R. 3613 Part D Beneficiary Appeals Fairness Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Funding for NIH, CDC, related to arthritis and rheumatic disease research; S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Monitor the implementation of the Continuing Appropriations Resolution, P.L. 112-175; H.R. 8 American Taxpayer Relief Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 6482 To amend the Congressional Budget Act of 1974 respecting the scoring of preventative health savings; H.R. 4209 Patients' Access to Treatments Act; H.R. 451 Healthcare, Truth and Transparency Act; H.R. 6352 Resident Physician Shortage Reduction and Graduate Medical Education Accountability and Transparency Act; H.R. 6562 Resident Physician Shortage Reduction Act; H.R. 5 Protecting Access to Healthcare Act; H.R. 2245 / S. 296 Preserving Access to Life-Saving Medications Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 22, 2012.
Original Filing: 300520120.xml
Lobbying Issues
Repeal Sustainable Growth Rate formula; H.R. 452 Medicare Decisions Accountability Act; H.R. 2020 / S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; H.R. 1700 / S. 1042 Medicare Patient Empowerment Act; H.R. 3613 Part D Beneficiary Appeals Fairness Act; H.R. 5707 Medicare Physician Payment Innovation Act; H.R. 6142 Assuring Medicare Stability and Access for Seniors Act; Monitor implementation of P.L. 111-148; Extension of Section 3111, P.L. 111-148
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HJRes. 117 Continuing Appropriations Resolution, 2013 (P.L. 112-175); Ryan FY13 Budget: A Path to Prosperity: A Blueprint for American Renewal; Funding for NIH, CDC, related to arthritis and rheumatic disease research; S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2013; Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 5 Protecting Access to Healthcare Act; H.R. 2245 / S. 296 Preserving Access to Life-Saving Medications Act; H.R. 3839 Drug Shortage Prevention Act; H.R. 4209 Patients' Access to Treatments Act; H.R. 6352 Resident Physician Shortage Reduction and Graduate Medical Education Accountability and Transparency Act; H.R. 6482 To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health services; H.R. 6562 Resident Physician Shortage Reduction Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 20, 2012.
Original Filing: 300499273.xml
Lobbying Issues
Repeal Sustainable Growth Rate formula; H.R. 5707 Medicare Physician Payment Innovation Act; H.R. 3613 Part D Beneficiary Appeals Fairness Act; H.R. 452 Medicare Decisions Accountability Act; S. 1042 / H.R. 1700 Medicare Patient Empowerment Act; H.R. 3399 Medicare and Medicaid FAST Act; S. 1096 / H.R. 2020 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; Monitor implementation of P.L. 111-148; Extension of Section 3111 of P.L. 111-148
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Ryan FY13 Budget: A Path to Prosperity: A Blueprint for American Renewal; S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013; House Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013; Funding for NIH, CDC, related to arthritis and rheumatic disease research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 4209 Patients' Access to Treatments Act; H.R. 5 Protecting Access to Healthcare Act; S. 296 / H.R. 2245 Preserving Access to Life-Saving Medications Act; S. 2069 / H.R. 3891 Spending Reductions through Innovations in Therapies Agenda Act; H.R. 3839 Drug Shortage Prevention Act; S. 2113 Transforming the Regulatory Environment to Accelerate Access to Treatments; S. 2516 Food and Drug Administration Safety and Innovation Act; H.R. 5849 Charity Care Tax Deduction for Physicians Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2012
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2012.
Original Filing: 300475307.xml
Lobbying Issues
Repeal Sustainable Growth Rate Formula; S. 1042 / H.R. 1700 Medicare Patient Empowerment Act; H.R. 3613 Part D Beneficiary Appeals Fairness Act; H.R. 3399 Medicare and Medicaid FAST Act; S. 1096 / H.R. 2020 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111 - 148); Extension of Section 3111 of P.L. 111-148
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Ryan FY 2013 Budget: A Path to Prosperity: A Blueprint for American Renewal; H.R. 3630 Temporary Payroll Tax Cut Continuation Act of 2011 (P.L. 112-96); Funding for NIH, CDC, related to arthritis and rheumatic disease research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 5 Protecting Access to Healthcare Act; S. 296 / H.R. 2245 Preserving Access to Life Saving Medications Act of 2011; H.R. 3839 Drug Shortage Prevention Act of 2012; H.R. 4209 Patients' Access to Treatments Act of 2012; S. 668 Health Care Bureaucrats Elimination Act; S. 660 PATIENTS Act of 2011; S. 2069 / H.R. 3891 Spending Reductions through Innovations in Therapies Agenda Act of 2012
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2011
AMERICAN COLLEGE OF RHEUMATOLOGY amended a lobbying report for in-house lobbying in Q42011 on Dec. 13, 2012
Original Filing: 300524589.xml
Lobbying Issues
Repeal Sustainable Growth Rate Formula; S. 1042 / H.R. 1700 Medicare Patient Empowerment Act; S. 1096 / H.R. 2020 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111 - 148); Extension of Section 3111 of P.L. 111-148
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. 1599 / H.R. 3070 Department of Labor, Health and Human Services, and Education Appropriations Act, 2012; Funding for NIH, CDC, related to arthritis and rheumatic disease research; H.J. Res. 79 Continuing Appropriations Resolution, 2012; H.R. 2112 Consolidated and Further Continuing Appropriations Act, 2012; H.R. 3630 Temporary Payroll Tax Cut Continuation Act of 2011
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 296 / H.R. 2245 Preserving Access to Life Saving Medications Act of 2011; S. 660 PATIENTS Act of 2011; S. 668 Health Care Bureaucrats Elimination Act; S. 1107 / H.R. 2033 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; H.R. 5 Help Efficient, Accessible, Low Cost, Timely Healthcare Act; S. 1699 Prescription Drug Cost Reduction Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2011
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 20, 2012.
Original Filing: 300450173.xml
Lobbying Issues
Repeal Sustainable Growth Rate Formula; S. 1042 / H.R. 1700 Medicare Patient Empowerment Act; S. 1096 / H.R. 2020 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111 - 148); Extension of Section 3111 of P.L. 111-148
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. 1599 / H.R. 3070 Department of Labor, Health and Human Services, and Education Appropriations Act, 2012; Funding for NIH, CDC, related to arthritis and rheumatic disease research; H.J. Res 79 Continuing Appropriations Resolution, 2012; H.R. 2112 Consolidated and Further Continuing Appropriations Act, 2012; H.R. 3630 Temporary Payroll Tax Cut Continuation Act of 2011
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 296 / H.R. 2245 Preserving Access to Life Saving Medications Act of 2011; S. 660 PATIENTS Act of 2011; S. 668 Health Care Bureaucrats Elimination Act; S. 1107 / H.R. 2033 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; H.R. 5 Help Efficient, Accessible, Low Cost, Timely Healthcare Act; S. 1699 Prescription Drug Cost Reduction Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2011
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Dec. 1, 2011.
Original Filing: 300433211.xml
Lobbying Issues
Repeal Sustainable Growth Rate formula; Extension of Section 3111 of P.L. 111-148; H.R. 2020 / S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; H.R. 1700 / S. 1042 Medicare Patient Empowerment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. 1599 / H.R. 3070; Department of Labor, Heath and Human Services, and Education Appropriations FY2012; Funding for NIH, CDC, related to arthritis and rheumatic disease research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 296 / H.R. 2245 Preserving Access to Life Saving Medications Act of 2011; S. 1107 / H.R. 2033 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; S. 218 / H.R. 5 Help Efficient, Accessible, Low-Cost, Timely Healthcare Act (HEALTH) of 2011; S. 668 Health Care Bureaucrats Elimination Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2011
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 19, 2011.
Original Filing: 300394671.xml
Lobbying Issues
Reinstatement of consultation codes under Medicare; Extension of Section 3111 of P.L 111-148; Repeal sustainable growth rate: HR 905 ; S. 733. Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 (H.R. 2020/ S. 1096)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Labor HHS Education Appropriations FY11; FY12; Funding for NIH, CDC, specifically related to arthritis research; Medicare cuts
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 4: Small Business Paperwork Elimination Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2011
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 18, 2011.
Original Filing: 300367055.xml
Lobbying Issues
H.R. 4: Small Business Paperwork Elimination Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Reinstatement of consultation codes under Medicare; Extension of Section 3111 of P.L 111-148; Repeal sustainable growth rate: HR 905 ; S. 733.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Labor HHS Education Appropriations FY11; FY12; Funding for NIH, CDC, specifically related to arthritis research.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2010
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 19, 2011.
Original Filing: 300345759.xml
Lobbying Issues
H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R. 3590 (111-148); H.R. 4872 (PL-111-152); H.R. 3962;
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R. 3590 (PL 111-148); H.R. 4872 (PL 111-152);
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1210/S.984: Arthritis Prevention Control and Cure Act of 2009;
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY2011 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2010
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 19, 2010.
Original Filing: 300320054.xml
Lobbying Issues
H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R. 3590 (111-148); H.R. 4872 (PL-111-152); H.R. 3962;
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R. 3590 (PL 111-148); H.R. 4872 (PL 111-152);
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1210/S.984: Arthritis Prevention Control and Cure Act of 2009;
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
FY2011 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2010
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 26, 2010.
Original Filing: 300304999.xml
Lobbying Issues
H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R. 3590 (111-148); H.R. 4872 (PL-111-152); H.R. 3962;
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R. 3590 (PL 111-148); H.R. 4872 (PL 111-152);
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1210/S.984: Arthritis Prevention Control and Cure Act of 2009;
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY2011 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2010
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on May 4, 2010.
Original Filing: 300278360.xml
Lobbying Issues
H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R. 3590 (111-148); H.R. 4872 (PL-111-152); H.R. 3962;
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R. 3590 (PL 111-148); H.R. 4872 (PL 111-152);
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1210/S.984: Arthritis Prevention Control and Cure Act of 2009;
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY2011 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2009
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 19, 2010.
Original Filing: 300235713.xml
Lobbying Issues
H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; health care reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.1 American Recovery and Reinvestment Act (P.L. 111-5); HIT in stimulus
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1210/S.984: Arthritis Prevention Control and Cure Act of 2009; H.R. 3200;
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
FY2010 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2009
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Oct. 13, 2009.
Original Filing: 300203109.xml
Lobbying Issues
H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; S.1042 health care reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.1 American Recovery and Reinvestment Act (P.L. 111-5); HIT in stimulus
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1210/S.984: Arthritis Prevention Control and Cure Act of 2009; H.R. 3200;
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
FY2009 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 17, 2009.
Original Filing: 300182991.xml
Lobbying Issues
H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; S.1042 health care reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.930: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.571 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1 American Recovery and Reinvestment Act (P.L. 111-5); HIT in stimulus
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1210: Arthritis Prevention Control and Cure Act of 2009
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
FY2009 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
S.3272 NIH emergency Supplemental Appropriations Act of 2008;
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2009
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300160352.xml
Lobbying Issues
H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R 583; S. 1042; H.R 6331 Medicare Improvements for Patients and Providers (P.L No. 110-275); H.R. 2 Childrend's Health Insureance Program Reauthorization Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.930: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.571 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; HIT funding in stimulus
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1210: Arthritis Prevention Control and Cure Act of 2009
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
FY2009 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
S.3272 NIH emergency Supplemental Appropriations Act of 2008; P.L. 110-329: Consolidated Security , Distaster Assistance and Continuing Approproations Act of 2009
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300130855.xml
Lobbying Issues
SCHIP Extension; H.R.3963: Physician Fee Schedule; Children's Health Insurance Program Reauthorization of 2007; CY2008 Physician Fee Schedule Sustainable Growth Rate issues; H.R.4206/S.2702: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R.583 Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007; S.1042/H.R.2931: Osteoporosis Early Detection and Prevention Act; H.R. 6331 Medicare Improvements for Patients (P.L. 110-275
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.1192/ S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; H.R.1188/S.1459 : Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1283: Arthritis Prevention Control and Cure Act of 2007; S.626: Arthritis Prevention Control and Cure Act of 2007
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
P.L. 110-173: Medicare, Medicaid, and SCHIP Extension Act of 2007
House FY2009 Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH ; S.3272: NIH Emergency Supplemental Appropriations Act; P.L 110-329: Consolidation Security, Distaster Assistance and Continuing Appropriations Act of 2009.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 7, 2009.
Original Filing: 300144131.xml
Lobbying Issues
SCHIP Extension Act fo 2007; H.R.3936: Physician Fee Schedule Issues; H.R.4206 and S.2702: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R.583 Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007; S. 1042 H.R. 2931: Osteoporosis Early Detection and Prevention Act of 2007; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 (P.L. No. 110-275)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.1283: Arthritis Prevention Control and Cure Act of 2007; S.626: Arthritis Prevention Control and Cure Act of 2007
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
P.L. 110-173: Medicare, Medicaid, and SCHIP Extension Act of 2007; House FY2009 Labor/HHS/Education Appropriations bill: funding for arthritis and rheumatic disease research at NIH; S. 3230 FY 2009 Emergency Supplemental Appropriations Act of 2008; P.L. 110-329: Consolidated Security, Disaster Assistance, and continuing appropriations Act of 2009.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.1192 Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendments of 2007; H.R.1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.1459 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2008
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on Jan. 8, 2009.
Original Filing: 300114787.xml
Lobbying Issues
SCHIP Extension Act fo 2007; H.R.3936: Physician Fee Schedule Issues; H.R.4206 and S.2702: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R.583 Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007; S. 1042 H.R. 2931: Osteoporosis Early Detection and Prevention Act of 2007; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 (P.L. No. 110-275)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.1192 Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendments of 2007; H.R.1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.1459 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1283: Arthritis Prevention Control and Cure Act of 2007; S.626: Arthritis Prevention Control and Cure Act of 2007
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
P.L. 110-173: Medicare, Medicaid, and SCHIP Extension Act of 2007; House FY2009 Labor/HHS/Education Appropriations bill: funding for arthritis and rheumatic disease research at NIH; S. 3230 FY 2009 Emergency Supplemental Appropriations Act of 2008; P.L. 110-329: Consolidated Security, Disaster Assistance, and continuing appropriations Act of 2009.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2008
In Q2, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on July 21, 2008.
Original Filing: 300077181.xml
Lobbying Issues
P.L 110-173: Medicare, Medicaid, and SCHIP Extension Act fo 2007; H.R.3963: Children's Health Insurance Program Reauthorization of 2007; CY2008 Physician Fee Schedule Sustainable Growth Rate issues; H.R.4206: Medicare Fracture Prevention & Osteoporosis Testing Act; S.2702 Medicare Fracture Prevention & Osteoporosis Testing Act of 2007; H.R.583 Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007; S.1042: Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007; H.R. Osteoporosis Early Detection and Prevention Act of 2007; H.R.6331 Medicare Improvements for Patients and Providers Act of 2008 (Pub.L.No. 110-275)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.1192 Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendments of 2007; H.R.1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.1459 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1283: Arthritis Prevention Control and Cure Act of 2007; S.626: Arthritis Prevention Control and Cure Act of 2007
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
P.L. 110-173: Medicare, Medicaid, and SCHIP Extension Act of 2007
Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2008
In Q1, AMERICAN COLLEGE OF RHEUMATOLOGY had in-house lobbyists. The report was filed on April 21, 2008.
Original Filing: 300048477.xml
Lobbying Issues
P.L 110-173: Medicare, Medicaid, and SCHIP Extension Act fo 2007; H.R.3936: Children's Health Insurance Program Reauthorization of 2007; CY2008 Physician Fee Schedule Sustainable Growth Rate issues; H.R.4206: Medicare Fracture Prevention & Osteoporosis Testing Act; S.2702 Medicare Fracture Prevention & Osteoporosis Testing Act of 2007; H.R.583 Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007; S.1042: Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007; H.R. Osteoporosis Early Detection and Prevention Act of 2007
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.1192 Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendments of 2007; H.R.1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.1459 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007
Agencies Lobbied
Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.1283: Arthritis Prevention Control and Cure Act of 2007; S.626: Arthritis Prevention Control and Cure Act of 2007
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
P.L. 110-173: Medicare, Medicaid, and SCHIP Extension Act of 2007
Labor/HHS/Education Appropriations bill - funding for arthritis and rheumatic disease research at NIH
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate